SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-051904
Filing Date
2018-09-21
Accepted
2018-09-21 16:44:57
Documents
1
Period of Report
2018-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3869
  Complete submission text file 0001209191-18-051904.txt   5494
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Joseph Donald (Reporting) CIK: 0001319460 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 181081975